• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗精神病药物治疗后的改善标准以及精神分裂症性精神病的临床和神经放射学因素。初步研究]

[Improvement criteria after neuroleptic treatment and clinical and neuroradiological factors in schizophrenic psychoses. Preliminary studies].

作者信息

Jarema M, Choma M, Poniatowska R, Krawczyk R, Kozłowski P

机构信息

Zakład Neuroradiologii IPiN w Warszawie.

出版信息

Psychiatr Pol. 1997 Jan-Feb;31(1):21-32.

PMID:9527652
Abstract

In 40 schizophrenic patients, various criteria of clinical improvement after neuroleptic treatment were compared in order to establish correlations between improvement after treatment and some clinical and MRI parameters. Three ways of evaluation of clinical improvement (CGI scale, PANSS index, percentage of improvement) correlated strongly with one another. Only the distribution of numbers of patients with different clinical improvement evaluated by the use of PANSS index was not statistically significant. Clinical improvement, evaluated with all three methods, significantly correlated with basal PANSS score as well as with the severity of positive symptoms and affective blunting, but not with the severity of schizophrenia negative symptoms. Only clinical improvement with the use of CGI demonstrated significantly better improvement in patients who had good previous response to neuroleptics. This particular method of clinical improvement evaluation, in contrast to other two methods, failed to reveal better response to neuroleptics among patients with no cortical atrophy found in MRI. Among patients with different improvement after treatment, evaluated with the use of all three methods, selected MRI parameters did not show significant differences with the exception of CGI improvement which correlated positively with the intensity of signal in T2-weighted image of gray matter in left medial frontal gyrus.

摘要

在40例精神分裂症患者中,比较了抗精神病药物治疗后临床改善的各种标准,以确定治疗后改善与一些临床和MRI参数之间的相关性。三种临床改善评估方法(CGI量表、PANSS指数、改善百分比)之间高度相关。仅使用PANSS指数评估的不同临床改善患者数量分布无统计学意义。用这三种方法评估的临床改善与基础PANSS评分以及阳性症状和情感迟钝的严重程度显著相关,但与精神分裂症阴性症状的严重程度无关。仅使用CGI评估的临床改善显示,既往对抗精神病药物反应良好的患者改善明显更好。与其他两种方法相比,这种特定的临床改善评估方法未能在MRI未发现皮质萎缩的患者中显示出对抗精神病药物的更好反应。在使用这三种方法评估的治疗后改善不同的患者中,除了CGI改善与左侧额内侧回灰质T2加权图像中的信号强度呈正相关外,所选的MRI参数没有显示出显著差异。

相似文献

1
[Improvement criteria after neuroleptic treatment and clinical and neuroradiological factors in schizophrenic psychoses. Preliminary studies].[抗精神病药物治疗后的改善标准以及精神分裂症性精神病的临床和神经放射学因素。初步研究]
Psychiatr Pol. 1997 Jan-Feb;31(1):21-32.
2
Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.佐替平与安慰剂治疗原发性阴性症状稳定的精神分裂症患者:一项随机双盲多中心试验。
Pharmacopsychiatry. 2004 Nov;37(6):270-8. doi: 10.1055/s-2004-832683.
3
[Cortical atrophy in MRI, mental status and neuroleptic treatment effect in schizophrenia].
Psychiatr Pol. 1997 Sep-Oct;31(5):547-57.
4
[Selected parameters of magnetic resonance imaging of the brain, clinical picture and recovery after treatment in schizophrenia. Preliminary report].[精神分裂症患者脑部磁共振成像的选定参数、临床表现及治疗后的恢复情况。初步报告]
Psychiatr Pol. 1997 Jan-Feb;31(1):33-46.
5
[Evaluation of the emotional blunting and its prognostic importance during neuroleptic treatment of schizophrenia].[精神分裂症患者使用抗精神病药物治疗期间情感迟钝的评估及其预后意义]
Psychiatr Pol. 2003 Nov-Dec;37(6):999-1012.
6
[Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].[长效注射用利培酮:阿基坦地区三家医院的自然主义研究]
Encephale. 2007 Dec;33(6):973-81. doi: 10.1016/j.encep.2006.07.003. Epub 2007 Sep 4.
7
Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.儿童期起病的精神分裂症与儿童期起病的非典型精神病进行性皮质灰质损失的比较。
Arch Gen Psychiatry. 2004 Jan;61(1):17-22. doi: 10.1001/archpsyc.61.1.17.
8
Patient-based and clinician-based support for the remission criteria in schizophrenia.基于患者和临床医生对精神分裂症缓解标准的支持。
Int Clin Psychopharmacol. 2007 Jan;22(1):51-5. doi: 10.1097/01.yic.0000224791.06159.88.
9
Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.氯氮平诱发的脑电地形图变化与精神分裂症患者的临床反应相关:一项前瞻性纵向研究。
Pharmacopsychiatry. 2004 May;37(3):119-22. doi: 10.1055/s-2004-818989.
10
Interictal psychoses in comparison with schizophrenia--a prospective study.发作间期精神病与精神分裂症的比较——一项前瞻性研究。
Epilepsia. 2007 Dec;48(12):2345-51. doi: 10.1111/j.1528-1167.2007.01230.x. Epub 2007 Jul 30.